SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Holdings
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robin Peterson who wrote (5)1/15/1997 6:54:00 PM
From: Robin Peterson   of 224
 
Hi Robin, visited BIO's office yesterday.

Priorities are:

(1) Finalize requirements for NASDAQ listing.This should be interesting, since the stock price will have to be double where it is now.

(2) Construct a tableting facility in Vancouver initially to supply the Carribbean market. Production capacity is set for 30m tablets a month. Using Chinese sale figures, 50% production (=sales) represents $57m revenues.

(3) Construct a facility in China, since initial demand has exceeded expectations.

(4) Conclude licensing agreement with a multi-national for N. America
and Europe.

Another Vancouver biotech company is Inflazyme Pharmaceutical, which has the same market cap as BIO. IZP has "potential", 3 years projected losses, and savvy marketing.BIO's marketing has been pathetic, but I'd rather be invested in a company at the manufacturing and marketing stage with projected revenues, than in one soaking up private placement money in promising research.

Robin

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News